Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase III study of lidocaine ointment for local anesthesia in electronic nasopharyngolaryngoscopy
CTR20263287Phase 3Active
- Sponsor
- Beijing Zhongtaibang Pharmaceutical Technology
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in procedural pain, sponsored by Beijing Zhongtaibang Pharmaceutical Technology. Started Aug 2026; status: active.
02
Drugs
lidocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on CTR20263287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263287.